U.S. High Growth Tech and AI Stocks

Commvault Systems

Market Cap: US$7.4b

Provides a cyber resilience platform for protecting and recovering data and cloud-native applications in the Americas and internationally.

Quoin Pharmaceuticals

Market Cap: US$4.9m

A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

Unicycive Therapeutics

Market Cap: US$58.3m

A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.

Vertex Pharmaceuticals

Market Cap: US$122.5b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

CleanSpark

Market Cap: US$3.5b

Operates as a bitcoin mining company in the Americas.

BeOne Medicines

Market Cap: US$35.0b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Anavex Life Sciences

Market Cap: US$1.1b

Operates as a biopharmaceutical company.

Krystal Biotech

Market Cap: US$4.4b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Semrush Holdings

Market Cap: US$1.5b

Develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally.

Evaxion

Market Cap: US$16.9m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

Glimpse Group

Market Cap: US$33.5m

An immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.

Amicus Therapeutics

Market Cap: US$1.9b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

Fennec Pharmaceuticals

Market Cap: US$241.1m

Operates as a commercial stage biopharmaceutical company in the United States.

MNTN

Market Cap: US$2.2b

A performance TV software company, provides performance advertising services in the United States.

Protalix BioTherapeutics

Market Cap: US$127.4m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

BitFuFu

Market Cap: US$665.5m

Provides digital asset mining solutions in North America, Asia, Europe, and internationally.

Day One Biopharmaceuticals

Market Cap: US$703.5m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

Creative Medical Technology Holdings

Market Cap: US$7.1m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

Clene

Market Cap: US$33.6m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

ServiceNow

Market Cap: US$198.4b

Provides cloud-based solution for digital workflows in the North America, Europe, the Middle East and Africa, Asia Pacific, and internationally.

Trade Desk

Market Cap: US$41.6b

Operates as a technology company in the United States and internationally.

IREN

Market Cap: US$4.6b

Operates in the integrated data center business.

Take-Two Interactive Software

Market Cap: US$41.8b

Develops, publishes, and markets interactive entertainment solutions for consumers worldwide.

Bit Digital

Market Cap: US$1.1b

Engages in the bitcoin mining business.

Corning

Market Cap: US$47.8b

Operates in optical communications, display technologies, environmental technologies, specialty materials, and life sciences businesses.

ImmunityBio

Market Cap: US$2.6b

A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.

Sierra Oncology

Market Cap: US$1.3b

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

Zai Lab

Market Cap: US$4.1b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

AmpliTech Group

Market Cap: US$55.3m

Designs, engineers, and assembles micro-wave component-based amplifiers.

Protagonist Therapeutics

Market Cap: US$3.4b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Aprea Therapeutics

Market Cap: US$10.7m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

Geron

Market Cap: US$847.1m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Bitdeer Technologies Group

Market Cap: US$2.9b

Operates as a technology company for blockchain and high-performance computing (HPC) in Singapore, the United States, Bhutan, and Norway.

Apellis Pharmaceuticals

Market Cap: US$2.5b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Applied Optoelectronics

Market Cap: US$1.5b

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

Alector

Market Cap: US$178.0m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.